Sort by:
Reset
Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK, Dash R, Yacoub A, Fuller CE, Shah K, Dent P, Bruce JN, Fisher PB
Astrocyte elevated gene-1: a novel target for human glioma therapy.
Mol Cancer Ther. 2010;9(1):79-88 - PMID: 20053777 - PMCID: PMC3165052 - DOI: 10.1158/1535-7163.MCT-09-0752
Framme C, Alt C, Schnell S, Brinkmann R, Lin CP
[Selective RPE laser treatment with a scanned cw laser beam in rabbits]
Ophthalmologie. 2005;102(5):491-6 - PMID: 15883846 - DOI: 10.1007/s00347-004-1139-5
Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palu G, Irimia D, Toner M, Weissleder R, Poznansky MC
Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control.
J Immunol. 2006;176(5):2902-14 - PMID: 16493048 - DOI: 10.4049/jimmunol.176.5.2902
Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD
Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity.
J Immunol. 2006;177:6991-8 - PMID: 17082614 - DOI: 10.4049/jimmunol.177.10.6991
Pittet M, Gati A, Le Gal F, Bioley G, Guillaume P, de Smedt M, Plum J, Speiser D, Cerottini J, Dietrich P, Romero P, Zippelius A
Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex.
J Immunol. 2006;176:2330-6 - PMID: 16455990 - DOI: 10.4049/jimmunol.176.4.2330
Zippelius A, Bioley G, Le Gal F, Rufer N, Brandes M, Batard P, De Smedt M, Plum J, Speiser D, Cerottini J, Dietrich P, Romero P, Pittet M
Human thymus exports naive CD8 T cells that can home to nonlymphoid tissues.
J Immunol. 2004;172:2773-7 - PMID: 14978076 - DOI: 10.4049/jimmunol.172.5.2773
Pittet M, Rubio-Godoy V, Bioley G, Guillaume P, Batard P, Speiser D, Luescher I, Cerottini J, Romero P, Zippelius A
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.
J Immunol. 2003;171:1844-9 - PMID: 12902485 - DOI: 10.4049/jimmunol.171.4.1844
Dietrich P, Le Gal F, Dutoit V, Pittet M, Trautman L, Zippelius A, Cognet I, Widmer V, Walker P, Michielin O, Guillaume P, Connerotte T, Jotereau F, Coulie P, Romero P, Cerottini J, Bonneville M, Valmori D
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
J Immunol. 2003;170:5103-9 - PMID: 12734356 - DOI: 10.4049/jimmunol.170.10.5103
Valmori D, Dutoit V, Schnuriger V, Quiquerez A, Pittet M, Guillaume P, Rubio-Godoy V, Walker P, Rimoldi D, Lienard D, Cerottini J, Romero P, Dietrich P
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
J Immunol. 2002;168:4231-40 - PMID: 11937585 - DOI: 10.4049/jimmunol.168.8.4231
Pittet M, Zippelius A, Speiser D, Assenmacher M, Guillaume P, Valmori D, Lienard D, Lejeune F, Cerottini J, Romero P
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
J Immunol. 2001;166:7634-40 - PMID: 11390521 - DOI: 10.4049/jimmunol.166.12.7634
Speiser D, Colonna M, Ayyoub M, Cella M, Pittet M, Batard P, Valmori D, Guillaume P, Lienard D, Cerottini J, Romero P
The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
J Immunol. 2001;167:6165-70 - PMID: 11714776 - DOI: 10.4049/jimmunol.167.11.6165
Pittet M, Speiser D, Valmori D, Cerottini J, Romero P
Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.
J Immunol. 2000;164:1148-52 - PMID: 10640724 - DOI: 10.4049/jimmunol.164.3.1148
Alvarez D, Swirski F, Yang T, Fattouh R, Croitoru K, Bramson J, Stampfli M, Jordana M
Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and nonmucosal tissues.
J Immunol. 2006;176(4):2568-80 - PMID: 16456019 - DOI: 10.4049/jimmunol.176.4.2568
Gajewska B, Tafuri A, Swirski F, Walker T, Johnson J, Shea T, Shahinian A, Goncharova S, Mak T, Stampfli M, Jordana M
B7RP-1 is not required for the generation of Th2 responses in a model of allergic airway inflammation but is essential for the induction of inhalation tolerance.
J Immunol. 2005;174(5):3000-5 - PMID: 15728513 - DOI: 10.4049/jimmunol.174.5.3000
Swirski F, Sajic D, Robbins C, Gajewska B, Jordana M, Stampfli M
Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor.
J Immunol. 2002;169:3499-506 - PMID: 12244139 - DOI: 10.4049/jimmunol.169.7.3499
Romero P, Zippelius A, Kurth I, Pittet M, Touvrey C, Iancu E, Corthesy P, Devevre E, Speiser D, Rufer N
Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes.
J Immunol. 2007;178(7):4112-9 - PMID: 17371966 - DOI: 10.4049/jimmunol.178.7.4112
Ito T*, Ueno T*, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H, Sayegh MH, Najafian N
Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
J Immunol. 2005;174(11):6648-56 - PMID: 15905503 - DOI: 10.4049/jimmunol.174.11.6648
Izawa A, Yamaura K, Albin MJ, Jurewicz M, Tanaka K, Clarkson MR, Ueno T, Habicht A, Freeman GJ, Yagita H, Abdi R, Pearson T, Greiner DL, Sayegh MH, Najafian N
A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.
J Immunol. 2007;179(2):786-96 - PMID: 17617568 - DOI: 10.4049/jimmunol.179.2.786
Tanaka K, Albin MJ, Yuan X, Yamaura K, Habicht A, Murayama T, Grimm M, Waaga AM, Ueno T, Padera RF, Yagita H, Azuma M, Shin T, Blazar BR, Rothstein DM, Sayegh MH, Najafian N
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
J Immunol. 2007;179(8):5204-10 - PMID: 17911605 - PMCID: PMC2291549 - DOI: 10.4049/jimmunol.179.8.5204
Boenisch O, D'Addio F, Watanabe T, Elyaman W, Magee CN, Yeung MY, Padera RF, Rodig SJ, Murayama T, Tanaka K, Yuan X, Ueno T, Jurisch A, Mfarrej B, Akiba H, Yagita H, Najafian N
TIM-3: a novel regulatory molecule of alloimmune activation.
J Immunol. 2010;185(10):5806-19 - PMID: 20956339 - PMCID: PMC3619947 - DOI: 10.4049/jimmunol.0903435
Xia Y, Cortez-Retamozo V, Niederkofler V, Salie R, Chen S, Samad TA, Hong CC, Arber S, Vyas JM, Weissleder R, Pittet MJ, Lin HY
Dragon (Repulsive Guidance Molecule b) Inhibits IL-6 Expression in Macrophages.
J Immunol. 2011;186(3):1369-76 - PMID: 21187450 - PMCID: PMC3670585 - DOI: 10.4049/jimmunol.1002047
Zhi L, Kim P, Thompson BD, Pitsillides C, Bankovich AJ, Yun SH, Lin CP, Cyster JG, Wu MX
FTY720 Blocks Egress of T Cells in Part by Abrogation of Their Adhesion on the Lymph Node Sinus.
J Immunol. 2011;187(5):2244-51 - PMID: 21788441 - PMCID: PMC3167479 - DOI: 10.4049/jimmunol.1100670
Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu MD, Wu J
Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells.
J Immunol. 2001;166(5):3130-42 - PMID: 11207265 - DOI: 10.4049/jimmunol.166.5.3130
Riella LV*, Ueno T*, Batal I, De Serres SA, Bassil R, Elyaman W, Yagita H, Medina-Pestana JO, Chandraker A, Najafian N
Blockade of notch ligand delta1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation.
J Immunol. 2011;187(9):4629-38 - PMID: 21949024 - PMCID: PMC3197868 - DOI: 10.4049/jimmunol.1004076
Misaghi S, Garris CS, Sun Y, Nguyen A, Zhang J, Sebrell A, Senger K, Yan D, Lorenzo MN, Heldens S, Lee WP, Xu M, Wu J, DeForge L, Sai T, Dixit VM, Zarrin AA
Increased targeting of donor switch region and IgE in Sgamma1-deficient B cells.
J Immunol. 2010;185(1):166-73 - PMID: 20511552 - DOI: 10.4049/jimmunol.1000515
Hilgendorf I, Swirski FK
Folate receptor: a macrophage "achilles' heel"?
J Am Heart Assoc. 2012;1(4):e004036 - PMID: 23130179 - PMCID: PMC3487350 - DOI: 10.1161/JAHA.112.004036
Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R.
Optical Imaging of Spontaneous Breast Tumors Using Protease Sensing
Invest Radiol. 2005;(6):321-327 - PMID: 15905717 - DOI: 10.1097/01.rli.0000163797.23172.90
Frank H, Loewe R, Loewe C, Oberhuber G, Schwaighofer B, Huber K, Weissleder R
Efficacy of thrombolytic therapy in pulmonary embolism determined by MION-enhanced MRA: an experimental study in rabbits.
Invest Radiol. 1998;33(12):853-7 - PMID: 9851818 - DOI: 10.1097/00004424-199812000-00002
Cheng HC, Khan MA, Bogdanov A, Kwong K, Weissleder R
Relative blood volume measurements by magnetic resonance imaging facilitate detection of testicular torsion.
Invest Radiol. 1997;32(12):763-9 - PMID: 9406017 - DOI: 10.1097/00004424-199712000-00007
Schulze E, Ferrucci JT, Poss K, Lapointe L, Bogdanova A, Weissleder R
Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro.
Invest Radiol. 1995;30(10):604-10 - PMID: 8557500 - DOI: 10.1097/00004424-199510000-00006
Weissleder R, Bogdanov A, Frank H, Nossiff N, Bogdanova A, Schaffer BK, Brady T, Wittenberg J
AUR Memorial Award 1993. A drug system (PDH) for interventional radiology. Synthesis, properties, and efficacy.
Invest Radiol. 1993;28(12):1083-9 - PMID: 8307710 - DOI: 10.1097/00004424-199312000-00001
Reimer P, Weissleder R, Nickeleit V, Brady TJ
Animal models for magnetic resonance imaging research of the liver.
Invest Radiol. 1992;27(5):390-3 - PMID: 1582824 - DOI: 10.1097/00004424-199205000-00014
Grüber G, Marshansky V
New insights into structure-function relationships between archeal ATP synthase (A1A0) and vacuolar type ATPase (V1V0).
Bioessays. 2008;30(11-12):1096-109 - PMID: 18937357 - DOI: 10.1002/bies.20827
Libby P, Nahrendorf M, Swirski FK
Monocyte heterogeneity in cardiovascular disease.
Semin Immunopathol. 2013;35(5):553-62 - PMID: 23839097 - PMCID: PMC3755757 - DOI: 10.1007/s00281-013-0387-3
Deramaudt TB, Takaoka M, Upadhyay R, Bowser MJ, Porter J, Lee A, Rhoades B, Johnstone CN, Weissleder R, Hingorani SR, Mahmood U, Rustgi AK
N-Cadherin and Keratinocyte Growth Factor Receptor Mediate the Functional Interplay between Ki-RASG12V and p53V143A in Promoting Pancreatic Cell Migration, Invasion, and Tissue Architecture Disruption.
Mol Cell Biol. 2006;26(11):4185-200 - PMID: 16705170 - PMCID: PMC1489079 - DOI: 10.1128/MCB.01055-05
Gabriely G, Wurdinger T, Kesari S, Esau C, Burchard J, Linsley P, Krichevsky A
MiR-21 Promotes Glioma Invasion by Targeting MMP Regulators.
Mol Cell Biol. 2008;28(17):5369-80 - PMID: 18591254 - PMCID: PMC2519720 - DOI: 10.1128/MCB.00479-08
Li X, Isono KI, Yamada D, Endo TA, Endoh M, Shinga J, Mizutani-Koseki Y, Otte AP, Casanova M, Kitamura H, Kamijo T, Sharif J, Ohara O, Toyada T, Bernstein BE, Brockdorff N, Koseki H
Mammalian Polycomblike Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate Polycomb activity at both the Hox gene cluster and at Cdkn2a genes.
Mol Cell Biol. 2010;31(2):351-64 - PMID: 21059868 - PMCID: PMC3019975 - DOI: 10.1128/MCB.00259-10
de Zoeten EF, Wang L, Butler K, Beier UH, Akimova T, Sai H, Bradner JE, Mazitschek R, Kozikowski AP, Matthias P, Hancock WW
HDAC6 and HSP90 Control The Functions Of Foxp3+ T-Regulatory Cells.
Mol Cell Biol. 2011;31(10):2066-78 - PMID: 21444725 - PMCID: PMC3133361 - DOI: 10.1128/MCB.05155-11
Fan KY, Gogineni H, Zaboli D, Lake S, Zahurak ML, Best SR, Levine MA, Tang M, Zinreich ES, Saunders JR, Califano JA, Blanco RG, Pai SI, Messing B, Ha PK
Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.
Ann Surg Oncol. 2012;19(6):1980-7 - PMID: 22290566 - PMCID: PMC3715048 - DOI: 10.1245/s10434-012-2219-4
Pai SI
Mission impossible: how HPV-associated head and neck cancers escape a primed immune response.
Oral Oncol. 2013;49(8):723-5 - PMID: 23643070 - DOI: 10.1016/j.oraloncology.2013.03.453
Joseph AW, Ogawa T, Bishop JA, Lyford-Pike S, Chang X, Phelps TH, Westra WH, Pai SI
Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.
Oral Oncol. 2012;49(3):244-8 - PMID: 23062994 - PMCID: PMC3548989 - DOI: 10.1016/j.oraloncology.2012.09.009
Shah K, Breakefield XO
HSV Amplicon Vectors for Cancer Therapy.
Curr Gene Ther. 2006;6(3):361-70 - PMID: 16787187 - DOI: 10.2174/156652306777592063
Sun CC, Vaja V, Babitt JL, Lin HY
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.
Am J Hematol. 2012;87(4):392-400 - PMID: 22290531 - PMCID: PMC3653431 - DOI: 10.1002/ajh.23110
Babitt JL, Lin HY
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD.
Am J Kidney Dis. 2010;55(4):726-41 - PMID: 20189278 - PMCID: PMC2905036 - DOI: 10.1053/j.ajkd.2009.12.030
Shayakul C, Breton S, Brown D, Alper SL
Gene therapy of inherited renal tubular disease.
Am J Kidney Dis. 1999;34(2):374-9 - PMID: 10430991 - DOI: 10.1016/s0272-6386(99)70372-0
Bishop JA, Maleki Z, Valsamakis A, Ogawa T, Chang X, Pai SI, Westra WH
Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.
Cancer Cytopathol. 2011;120(1):18-25 - PMID: 21751428 - PMCID: PMC3197962 - DOI: 10.1002/cncy.20175
Gultepe E, Reynoso FJ, Jhaveri A, Kulkarni P, Nagesha D, Ferris C, Harisinghani M, Campbell RB, Sridhar S
Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution.
Nanomedicine (Lond). 2010;5(8):1173-82 - PMID: 21039195 - DOI: 10.2217/nnm.10.84
Chen HH, Feng Y, Zhang M, Chao W, Josephson L, Shaw SY, Sosnovik DE
Protective Effect of the Apoptosis-Sensing Nanoparticle AnxCLIO-Cy5.5.
Nanomedicine (Lond). 2011;8(3):291-298 - PMID: 21704591 - PMCID: PMC3319055 - DOI: 10.1016/j.nano.2011.06.012
McCarthy JR, Jaffer FA
The role of nanomedicine in the imaging and therapy of thrombosis.
Nanomedicine (Lond). 2011;6(8):1291-3 - PMID: 22026372 - PMCID: PMC3332076 - DOI: 10.2217/nnm.11.128
Weissleder R, Castro C
Interview: Nanomedicine in oncology: miniaturized means to an enormous end.
Nanomedicine (Lond). 2011;6(9):1495-8 - PMID: 22077461 - DOI: 10.2217/nnm.11.138
1847 CSV HTML